Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort - Scheiner, B; Kirstein, M M; Hucke, F (Aliment Pharmacol Ther, 2019)